Cancer Studies

Cancer Studies aims at providing a platform for the dissemination of information among the broad discipline of oncology, including physiology, prevention, diagnosis, and treatment. The journal seeks to appeal audience of oncology and related subjects by publishing original research and review articles concerning clinical trials, epidemiology, molecular and cellular biology, and cancer genetics. Cancer Studies facilitates the wider dissemination of knowledge in order to substantially contribute to early detection, diagnosis, and cure to improve survival rate and quality of life of patients.

Coverage includes

  • Epidemiology
  • Prognosis and Treatment
  • Clinical and Molecular Therapeutics
  • Diagnostic Imaging Techniques
  • Evidence-based Medicine
  • Staging
  • Pharmacoeconomics and outcomes research
  • Systemic therapies
  • Radiotherapy
  • Chemotherapy
  • Pathology
  • Palliative Care
  • Surgical approaches
  • Molecular diagnostics
  • Adjuvant therapy
  • Biomarkers
  • Clinical trials
  • Comparative effectiveness
  • Molecular biology of disease
  • Risk and prevention

Editorial Contact

Prof Masayoshi Yamaguchi, Editor in Chief

Journal Information

ISSN: 2576-8263

Current Volume: Volume 1, Issue 1

Open Access: For all article types

Average time to first decision: 32 days

Benefits of publishing with us

Open Access
All articles published by Cancer Studies are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers.

Article Processing Charges
Cancer Studies accomplishes global open access. The journal, therefore, levies an affordable article-processing charge of $450 for each article accepted for publication.

Peer Review — High standard, rigorous peer review
All articles that reach us undergo a double-blind peer review by at least two anonymous reviewers before being considered for publication in the journal.

Post-publication Open Peer Review
Following publication, the peer review comments would be made open for anyone to read. The authors have the option to make the peer review history publicly available after publication.

Research Promotion
Increased credibility and wider dissemination of published articles.


FEATURED ARTICLES

Editor-in-Chief

Masayoshi Yamaguchi

Department of Pathology and Laboratory Medicine
University of California at Los Angeles, USA

Editorial Board

Thamil Selvee Ramasamy

Department of Molecular Medicine
Faculty of Medicine, University of Malaya, Malaysia

Rachna T. Shroff

MD Anderson Cancer Center
The University of Texas, USA

David Huang

Medical Physics
Duke Kunshan University, China

Lonzetta L. Newman

Department of Clinical Cancer Prevention
University of Texas MD Anderson Cancer Center, USA

James L. Cox

Kirksville College of Osteopathic Medicine
A.T. Still University, USA

Giorgio Bogani

Medical Director
National Cancer Institute (INT), Italy

James CHIM Chor Sang

Department of Medicine
The University of Hong Kong, Hong Kong

Xianquan Zhan

Xiangya Hospital
Central South University, China

Shi-Yong Sun

Department of Hematology and Medical Oncology
Emory University, USA

Rayudu Gopalakrishna

Department of Cell and Neurobiology
University of Southern California, USA

Vittorio Gebbia

Medical Oncology Unit
University of Palermo, Italy

Adrian Pablo Huñis

Centro Oncológico Buenos Aires
University of Buenos Aires, Argentina

Vladimir Zaichick

Neutron Activation and X-Ray Fluorescent Analysis
Medical Radiological Research Centre, Russia

Fang-yu Chou

College of Health and Social Sciences
San Francisco State University, USA

Noah Isakov

Department of Microbiology, Immunology and Genetics
Ben Gurion University of the Negev, Israel

Juliana Hamzah

Harry Perkins Institute of Medical Research, Australia

Wen-Chin Huang

Graduate Institute of Biomedical Sciences
China Medical University, Taiwan

Domenica Lorusso

Department of Gynaecologic Oncology
Catholic University of the Sacred Heart, Italy

Zsolt Baranyai

1st Department of Surgery
Semmelweis University, Hungary

Mansoor Raza Mirza

Department of Oncology
Copenhagen University Hospital, Denmark

Stefano Scabini

Unit of Surgical Oncology
IRCCS SAN MARTINO-IST, Italy

Wan-Ping Yang

Department of Nursing
Fooyin University, Taiwan

Svilen P. Sabchevski

Institute of Electronics
Bulgarian Academy of Sciences, Bulgaria

Barbara Jarzab

Department of Nuclear Medicine and Endocrine Oncology
Centrum Onkologii – Instytut, Poland

Mohammad Nezami

Cancer Immunologist
Pacific Medical Center of Hope, USA

Guidelines for Submission


Manuscript Preparation


Submission and Components

Submissions to Rivera journals should include the following:

  • Cover Letter
  • Manuscript
  • Figures and Tables
  • Supplemental Materials

Authors are encouraged to submit all the components as 'zip file' while submitting on our online system or via email as an attachment.

Cover Letter should:

  • briefly summarize or provide an outline of your manuscript, and why it is a worthy contribution to the concerned journal;
  • specify the Rivera journal that your manuscript best pertains to;
  • indicate, if applicable, that it is submitted as a part of Special Issue;
  • specify the manuscript type (original research, review, etc.)
  • detail any previous interaction(s) with Rivera Publications (previously submitted)
  • specify all authors' information, including affiliation 
  • include acknowledgments and funding information (if applicable) and any competing interests

Authors

All persons who qualify for authorship should be listed as authors. However, the corresponding author must ensure that each author listed has substantially contributed or participated sufficiently in the work and is responsible for that particular portion of the manuscript. However, people who do not qualify for authorship should be listed in acknowledgments.

One author (corresponding author) should be listed with an asterisk and should provide his or her email address. For the remaining authors, if applicable, following information should be included:

  • First name and last name
  • Complete affiliation, along with the country
  • Email address (optional, but mandatory for the corresponding author)

For example:

Robert Ludwig1

Yale University, New Haven, Connecticut, USA

Acknowledgements

This should include all the people who have contributed toward the work in one way or the other. However, authors are required to ensure that people acknowledged should agree to being so named.

Funding Information

List all the sources of funding, including relevant research grant numbers, as applicable. Also, authors are encouraged to list all the contributing authors associated with specific funding, if applicable.

Conflict of interest

The corresponding author is required to provide a statement of conflict of interest on behalf of all the authors. For further information, please refer to our Conflict of Interest Policy page.

Optional information

While we are not obligated to use these or recommend to the concerned Editor(s), we do encourage authors to provide names and contact information of 2-4 external reviewers and, if applicable, 1-2 opposed reviewers.

Manuscript Layout

The word count for original research is 3500–4000 words and up to 5500 words for studies involving meta-analysis. Authors are encouraged to employ a standard and concise writing style. If you are not a native English speaker, we encourage you to utilize our language editing services-or ask a native English speaking colleague for assistance.

All manuscript submissions can have the following sections:

  • Title
  • Abstract
  • Keywords
  • Main Text

    1. Introduction
    2. Materials and methods
    3. Results
    4. Discussion
    5. Conclusion(s)
    6. References

Title

The title should not exceed 200 characters and set in title case. The title should be concise, specific, and easily comprehensible to readers.

Abstract

The abstract should not exceed 300 words and should be unstructured (without sub-heading such as objective, methodology, results, discussion, etc.). It should provide a clear description of the objective(s) of the study, demonstrate the methodology used, and summarize the study's prime conclusion(s). At the end, a statement regarding the study's significance to a potentially wider audience should be included.

Keywords

Authors can provide 4-6 keywords. The first letter of each keyword should be upper case, and keywords should be separated by a semicolon (;).

References

Published work along with any citable items should be cited in the reference list. While we follow very stringent reference formats, authors need not to spend time formatting their reference. They can submit the manuscripts formatted in any reference style (style will be formatted once the manuscript is accepted for publication), but it is preferable that they adhere to the journal format.

For Health and Medicine

Rivera uses AMA style. Items are listed numerically in the order they are cited in the text.

Example journal article (2-6 authors): Salwachter AR, Freischlag JA, Sawyer RG, Sanfey HA. The training needs and priorities of male and female surgeons and their trainees. J Am Coll Surg. 2005; 201: 199-205.

Example journal article (more than 6 authors): Fukushima H, Cureoglu S, Schachern P, et al. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol Head Neck Surg. 2005; 133: 100-6.

Example book: Modlin J, Jenkins P. Decision Analysis in Planning for a Polio Outbreak in the United States. San Francisco, CA: Pediatric Academic Societies; 2004.

Example book chapter: Solensky R. Drug allergy: desensitization and treatment of reactions to antibiotics and aspirin. In: Lockey P, ed. Allergens and Allergen Immunotherapy. 3rd ed. New York, NY: Marcel Dekker; 2004:585-606.

Example online article: Wolf W. State's mail-order drug plan launched. Minneapolis Star Tribune. May 14, 2004:1B.

Example article from any database: Calhoun D, Trimarco T, Meek R, Locasto D. Distinguishing diabetes: Differentiate between type 1 & type 2 DM. JEMS [serial online]. November 2011; 36(11):32-48. Available from: CINAHL Plus with Full Text, Ipswich, MA. Accessed February 2, 2012.

In-text citation: For referencing an article, a number is used. This is different from in-text citations in AMAauthor's last name is not used. The order of numbering will be contingent on the order in which you use that reference within your paper. For example, the first article referenced will be given number one in superscript (1) followed by second and third articles as 2,3. In references section, the articles should appear numerically in the order they are cited within the text.

Figures and Tables

Figures and tables should be included in the main text (manuscript) to aid in the review process. However, for larger files (size exceeding 10 Mb) must always be submitted separately (should be properly mentioned in the main text, wherever applicable).

Figure captions and legends

Figure files should be included in the main document, and not as supplemental materials. Figure caption should be preceded by the figure, while figure legends should immediately follow the figure. Figure captions should be concise (not to exceed 18 words) and set in bold type. All figures should be numbered in sequence, using Arabic numerals, for example, Figure 1, Figure 2, etc.

Table captions and legends

Tables should be cited in ascending numeric order. Each table should be preceded by a table caption (brief and specific; not to exceed 18 words), and immediately followed by table legends, if applicable, used to explain abbreviations and other supporting information about the data. Larger tables, however, can be submitted as supplemental materials.


Review Comments and Revision


Submission Instructions

While submitting a revised manuscript, the authors should include the following:

Revised manuscript (clean copy): Prepare a clean copy of your revised manuscript that does not show track changes. Rename this file as "Main Document".

Revised manuscript (marked-up copy): Include a copy of your manuscript file showing the changes you have made (track changes). Rename this file as "Manuscript with Track Changes".

Response to reviewers: Address the specific points made by each Reviewer and/or Editor. Include your responses to all the reviewers' and editor's comments and list the changes you have made to the manuscript. Rename this file as "Response to Reviewers".

Supplementary Information

Information integral to the comprehensive understanding of the manuscript, but is either too large to be included in the main document or due to any other reason, should be submitted as support materials, such as 3-D visualizations, interactive graphics, large tables and/or figures, and so on. However, authors should note that normal figures and tables should not be included under supplemental materials.

Ethical Guidelines

For manuscripts reporting medical studies that involve human or animal subjects, ethics committee that approved the study must be identified in the manuscript. For studies involving human subjects, all work must conform to the recognized standards as per the "Declaration of Helsinki". In case of any experiments involving animals, authors must provide a declaration that all measures were taken to avoid animal suffering at each stage and also must furnish a detailed description of the procedures used. 

Patient Consent

In manuscripts reporting patient cases, patient anonymity must be preserved. Case reports submitted to Rivera Publications should conform to the International Committee of Medical Journal Editors' (ICMJE) recommendations. Patient privacy should be taken care of, and personally identifiable information should not be revealed without informed consent. If informed consent has been obtained, the details must be mentioned in the manuscript.

For live patients, signed consent is mandatory if the authors wish to reveal the patient's identity. In case of deceased patients, consent must be taken from patient's next of kin. If patient's consent was not obtained, patient's details should be anonymized as much as possible. Patient's photographs need to be cropped sufficiently to prevent revelation of identity.

Authors are not required to submit the copy of the patient's consent while submitting their manuscript for consideration in Rivera Publications. However, they should confirm in the Cover Letter that the patient's consent has been obtained. In certain instances, the Editorial Office might request the authors to provide a copy of the same.

Articles in Press


Volume 2, Issue 1


Variation in Selected Chemical Element Contents Associated with Malignant Tumors of Human Thyroid Gland 

Vladimir Zaichick and Sofia Zaichick

Review: Cancer-Stud 2(1): 1

Apr 06, 2018   


Volume 1, Issue 1


The Emerging Need for Education of the Primary Care Physician in Clinical Cancer Prevention and Survivorship Care 

Lonzetta L. Newman and Elise D. Cook

Editorial: Cancer Stud 1(1): 1

Jun 10, 2017   


Involvement of Regucalcin in Human Carcinogenesis Prevention 

Masayoshi Yamaguchi

Review: Cancer Stud 1(1): 2

Sep 17, 2017   


Persistent Risk for HBV Associated Hepatocellular Carcinoma in spite of Sustained and Successful Viral Suppression: The Need for Drugs for HBV Cure 

Shady Guirguis, Richard Hann and Hie-Won Hann

Editorial: Cancer Stud 1(1): 3

Oct 18, 2017   


Baseline Detection of Potential Cancer Biomarkers with Linear Models from Microarray Experiments 

Eulisa M. Rivera, Zahira I. Irizarry, Matilde L. Sánchez-Peña, M. Cabrera-Ríos and C.E. Isaza

Short Communication: Cancer Stud 1(1): 4

Dec 31, 2017   


The Role of Metastasectomy in Women with Solitary Metastatic Breast Cancer Recurrence 

Patrick Mun Yew Chan, Sherwin Kuah, Mui Heng Goh, Sarah Qinghui Lu, Juliana Jia Chuan Chen and Ern Yu Tan

Research: Cancer Stud 1(1): 5

Jan 12, 2018   


No Data Found

X